Literature DB >> 20693944

The new Oxford Clinico-Pathological Classification of IgA nephropathy.

R Coppo1, D Cattran, S D Roberts Ian, S Troyanov, R Camilla, T Cook, J Feehally.   

Abstract

The new Oxford Classification of the Pathology of IgA nephropathy originated from an international collaborative effort of the Working Group of the International IgA Nephropathy Network and Renal Pathology Society. It provides a new common language to categorizing glomerular and tubulo-interstitial lesions in IgA nephropathy having a proved effect on progression. Although retrospective in design and requiring future prospective validation, the Oxford collaboration defined and scored four pathologic parameters having an influence on outcome (independently of clinical information at renal biopsy or during follow-up); including mesangial (M) and endocapillary (E) proliferation (hypercellularity), glomerulosclerosis (S) and tubular atrophy and interstitial fibrosis (T). The scheme will likely become known as the OXFORD-MEST scoring system.

Entities:  

Mesh:

Year:  2010        PMID: 20693944

Source DB:  PubMed          Journal:  Prilozi        ISSN: 0351-3254


  5 in total

1.  Effects of rhein on intestinal epithelial tight junction in IgA nephropathy.

Authors:  Sheng-Nan Peng; Hui-Hong Zeng; Ai-Xiang Fu; Xiao-Wen Chen; Qing-Xian Zhu
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

2.  Correlates of hematuria on glomerular histology and electron microscopy in IgA nephropathy.

Authors:  Rohit Tewari; Ritambhra Nada; Maninder Kaur; Puja Dudeja; Charan Singh Rayat; Vinay Sakhuja; Kusum Joshi
Journal:  Med J Armed Forces India       Date:  2016-03-29

3.  The Usefulness of Vanin-1 and Periostin as Markers of an Active Autoimmune Process or Renal Fibrosis in Children with IgA Nephropathy and IgA Vasculitis with Nephritis-A Pilot Study.

Authors:  Małgorzata Mizerska-Wasiak; Emilia Płatos; Karolina Cichoń-Kawa; Urszula Demkow; Małgorzata Pańczyk-Tomaszewska
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

4.  Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy.

Authors:  Mian-Na Luo; Cui-Wei Yao; Bi-Hua Xu; Yong-Zhi Xu; Wei Jing Liu; Yong-Min Feng; Jing-Li Tao; Hua-Feng Liu
Journal:  Exp Ther Med       Date:  2013-12-31       Impact factor: 2.447

5.  UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohort.

Authors:  Miriana Dinic; Lidia Ghisdal; Judith Racapé; Lise Thibaudin; Philippe Gatault; Marie Essig; Yann Le Meur; Christian Noël; Guy Touchard; Pierre Merville; Zineb Ajarchouh; Christophe Mariat; Marc Abramowicz; Daniel Abramowicz; Eric Alamartine
Journal:  BMC Nephrol       Date:  2014-08-28       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.